Portfolio Holdings Detail for ISIN IE000YNE6S57
Stock Name / Fund | ISHETF756290XAMS |
Issuer | Blackrock |
Entity holding fund | iShares V Public Limited Company |
Entity Type | |
Entity LEI | 549300QETNU1W5JY7Z94 |
ETF Ticker | WCTD(USD) Euronext Amsterdam |
Holdings detail for ABBV
Stock Name | AbbVie Inc |
Ticker | ABBV(USD) NYSE |
TYPE | Common Stock |
Country | USA |
ISIN | US00287Y1091 |
LEI | FR5LCKFTG8054YNNRU85 |
Show aggregate ABBV holdings
News associated with ABBV
- Vanguard High Dividend Yield ETF vs Vanguard Dividend Appreciation ETF: Which Is Best for You?
- The Vanguard High Dividend Yield ETF (NYSEMKT: VYM) and the Vanguard Dividend Appreciation ETF (NYSEMKT: VIG) are two of the most popular dividend stock ETFs in the market. However, they have different investment objectives, and therefore one of them might be more appropriate for - 2025-03-11 13:21:00
- 3 Cheap Stocks to Buy With Your Tax Refund Check
- The average tax refund in 2024 was $3,138, which was similar to the $3,167 it averaged the previous year. While tax refunds will vary depending on a person's individual financial situation, if you receive one, it can provide you with some extra cash you can put toward paying down - 2025-03-07 10:30:00
- 2 Dividend Stocks to Buy for a Lifetime of Passive Income
- Dividend investors don't buy shares of companies hoping they will suspend their payouts soon. The longer a corporation maintains its dividend program, the more attractive it is to income seekers, all else being equal. However, few businesses on Wall Street can sustain consistent - 2025-03-07 10:03:00
- VTV, WMT, ABBV, CSCO: Large Inflows Detected at ETF
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Value ETF (Symbol: VTV) where we have detected an approximate $1.0 billion dollar inflow -- that's a 0.8% increase week over week in outstan - 2025-03-06 16:21:27
- Bank of America Raises AbbVie (NYSE:ABBV) Price Target to $223.00
- AbbVie (NYSE:ABBV – Get Free Report) had its price target upped by equities research analysts at Bank of America from $200.00 to $223.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Bank of America‘s price objective suggests a potential upside of 5.38% from the stock’s previous […] - 2025-03-06 10:24:59
- AbbVie (NYSE:ABBV) Shares Up 0.6% Following Analyst Upgrade
- Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0.6% on Wednesday after Wells Fargo & Company raised their price target on the stock from $210.00 to $240.00. Wells Fargo & Company currently has an overweight rating on the stock. AbbVie traded as high as $211.13 and last traded at $209.01. 1,149,669 shares […] - 2025-03-06 08:55:58
- AbbVie Reaches Analyst Target Price
- In recent trading, shares of AbbVie Inc (Symbol: ABBV) have crossed above the average analyst 12-month target price of $207.60, changing hands for $209.03/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati - 2025-03-03 12:46:52
- AbbVie, Gubra Enter License Agreement To Develop GUB014295 - Quick Facts
- (RTTNews) - AbbVie (ABBV) and Gubra A/S announced a license agreement to develop GUB014295, a potential long-acting amylin analog for the treatment of obesity. AbbVie will lead development and commercialization activities of GUB014295 globally. Gubra will receive $350 million in - 2025-03-03 06:26:52
- AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?
- AbbVie has outperformed the healthcare sector over the past year, and analysts are moderately optimistic about the stock’s prospects. - 2025-02-28 18:26:29
- AbbVie's Upadacitinib Gets Positive CHMP Opinion For Treatment Of Adults With Giant Cell Arteritis
- (RTTNews) - AbbVie (ABBV) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of upadacitinib (RINVOQ; 15 mg, once daily) for the treatment of adult patients with giant cell arte - 2025-02-28 07:33:37
- Strategic Financial Concepts LLC Acquires 845 Shares of AbbVie Inc. (NYSE:ABBV)
- Strategic Financial Concepts LLC boosted its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 56.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,329 shares of the company’s stock after purchasing an additional 845 shares during […] - 2025-02-21 09:07:04
- 4 Stocks and 1 Exchange-Traded Fund (ETF) I Can't Stop Buying
- In today's video, I unveil five of my favorite investments, four stocks and one ETF. One of the stocks is Amazon (NASDAQ: AMZN). - 2025-02-19 15:42:30
- Fund Update: JANUS HENDERSON GROUP PLC Just Disclosed New Holdings
- JANUS HENDERSON GROUP PLC just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-14 17:50:36
- Fund Update: T. Rowe Price Investment Management, Inc. Just Disclosed New Holdings
- T. Rowe Price Investment Management, Inc. just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other f - 2025-02-14 15:16:37
- Fund Update: ONTARIO TEACHERS PENSION PLAN BOARD Just Disclosed New Holdings
- ONTARIO TEACHERS PENSION PLAN BOARD just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-13 21:38:37
- Fund Update: Capital International Investors Just Disclosed New Holdings
- Capital International Investors just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-13 18:55:34
- Daily Dividend Report: RHI,CSCO,ABBV,PSX,MDLZ
- Robert Half today announced that its board of directors has approved an increase to its quarterly cash dividend, from $0.53 to $0.59 per share. The cash dividend will be paid on March 14, 2025, to all shareholders of record as of Feb. 25, 2025.
Cisco has declared a quarterly di - 2025-02-13 17:50:05
- SCHD, RSBA: Big ETF Inflows
- Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the Schwab US Dividend Equity ETF, which added 10,250,000 units, or a 0.4% increase week over week. Among the largest underlying components of SCHD, i - 2025-02-13 15:48:40
- SPYD, SDP: Big ETF Outflows
- Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the SPDR Portfolio S&P 500 High Dividend ETF, where 22,900,000 units were destroyed, or a 12.9% decrease week over week. Among the largest - 2025-02-11 16:12:12
- Fund Update: TOCQUEVILLE ASSET MANAGEMENT L.P. Just Disclosed New Holdings
- TOCQUEVILLE ASSET MANAGEMENT L.P. just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-10 22:06:10
- Fund Update: Advisors Asset Management, Inc. Just Disclosed New Holdings
- Advisors Asset Management, Inc. just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-10 20:53:37
- Capital Group Core Equity ETF Experiences Big Inflow
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Core Equity ETF (Symbol: CGUS) where we have detected an approximate $318.6 million dollar inflow -- that's a 6.7% increase week over w - 2025-02-10 18:07:14
- Is Invesco Large Cap Value ETF (PWV) a Strong ETF Right Now?
- Smart Beta ETF report for PWV - 2025-02-10 11:20:07
- Leerink Partnrs Estimates AbbVie’s Q1 Earnings (NYSE:ABBV)
- AbbVie Inc. (NYSE:ABBV – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of AbbVie in a research note issued to investors on Monday, February 3rd. Leerink Partnrs analyst D. Risinger anticipates that the company will post earnings of $2.50 per share for the […] - 2025-02-06 07:10:47
- Is Wall Street Bullish or Bearish on AbbVie Stock?
- Despite AbbVie's underperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock's future. - 2025-02-05 12:35:42
- AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
- AbbVie (NYSE:ABBV – Get Free Report) had its target price raised by equities research analysts at Wells Fargo & Company from $195.00 to $210.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 10.54% […] - 2025-02-05 12:27:09
- AbbVie (NYSE:ABBV) Price Target Raised to $190.00 at UBS Group
- AbbVie (NYSE:ABBV – Get Free Report) had its price target lifted by equities researchers at UBS Group from $181.00 to $190.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target indicates a potential upside of 0.01% from the stock’s previous close. […] - 2025-02-05 12:27:04
- Citigroup Boosts AbbVie (NYSE:ABBV) Price Target to $215.00
- AbbVie (NYSE:ABBV – Get Free Report) had its price objective upped by stock analysts at Citigroup from $205.00 to $215.00 in a report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Citigroup’s price objective would indicate a potential upside of 13.17% from the company’s previous close. ABBV has been […] - 2025-02-05 10:07:16
- Guggenheim Raises AbbVie (NYSE:ABBV) Price Target to $214.00
- AbbVie (NYSE:ABBV – Get Free Report) had its price target upped by stock analysts at Guggenheim from $212.00 to $214.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price objective would suggest a potential upside of 12.65% from the stock’s previous close. […] - 2025-02-05 09:24:56
- AbbVie (NYSE:ABBV) Price Target Raised to $215.00 at BMO Capital Markets
- AbbVie (NYSE:ABBV – Get Free Report) had its price objective lifted by equities research analysts at BMO Capital Markets from $208.00 to $215.00 in a note issued to investors on Monday, Marketbeat reports. The brokerage presently has an “outperform” rating on the stock. BMO Capital Markets’ price target would indicate a potential upside of 13.17% […] - 2025-02-05 09:24:56
ISHETF756290XAMS ABBV holdings
Date | Number of ABBV Shares Held | Base Market Value of ABBV Shares | Local Market Value of ABBV Shares | Change in ABBV Shares Held | Change in ABBV Base Value | Current Price per ABBV Share Held | Previous Price per ABBV Share Held |
---|
2025-03-10 (Monday) | 284 | USD 61,531 | USD 61,531 | 0 | USD 673 | USD 216.658 | USD 214.289 |
2025-03-07 (Friday) | 284 | USD 60,858 | USD 60,858 | 0 | USD 781 | USD 214.289 | USD 211.539 |
2025-03-05 (Wednesday) | 284 | USD 60,077 | USD 60,077 | 0 | USD 1,073 | USD 211.539 | USD 207.761 |
2025-03-04 (Tuesday) | 284 | USD 59,004 | USD 59,004 | 0 | USD -1,056 | USD 207.761 | USD 211.479 |
2025-03-03 (Monday) | 284 | USD 60,060 | USD 60,060 | 0 | USD 695 | USD 211.479 | USD 209.032 |
2025-02-28 (Friday) | 284 | USD 59,365 | USD 59,365 | 0 | USD 1,139 | USD 209.032 | USD 205.021 |
2025-02-27 (Thursday) | 284 | USD 58,226 | USD 58,226 | 0 | USD 571 | USD 205.021 | USD 203.011 |
2025-02-26 (Wednesday) | 284 | USD 57,655 | USD 57,655 | 0 | USD -321 | USD 203.011 | USD 204.141 |
2025-02-25 (Tuesday) | 284 | USD 57,976 | USD 57,976 | 0 | USD 17 | USD 204.141 | USD 204.081 |
2025-02-24 (Monday) | 284 | USD 57,959 | USD 57,959 | 0 | USD 568 | USD 204.081 | USD 202.081 |
2025-02-21 (Friday) | 284 | USD 57,391 | USD 57,391 | 0 | USD 341 | USD 202.081 | USD 200.88 |
2025-02-20 (Thursday) | 284 | USD 57,050 | USD 57,050 | 0 | USD 1,003 | USD 200.88 | USD 197.349 |
2025-02-19 (Wednesday) | 284 | USD 56,047 | USD 56,047 | 0 | USD 312 | USD 197.349 | USD 196.25 |
2025-02-18 (Tuesday) | 284 | USD 55,735 | USD 55,735 | 0 | USD 960 | USD 196.25 | USD 192.87 |
2025-02-17 (Monday) | 284 | USD 54,775 | USD 54,775 | 0 | USD 0 | USD 192.87 | USD 192.87 |
2025-02-14 (Friday) | 284 | USD 54,775 | USD 54,775 | 0 | USD -165 | USD 192.87 | USD 193.451 |
2025-02-13 (Thursday) | 284 | USD 54,940 | USD 54,940 | 0 | USD 128 | USD 193.451 | USD 193 |
2025-02-12 (Wednesday) | 284 | USD 54,812 | USD 54,812 | 0 | USD 332 | USD 193 | USD 191.831 |
2025-02-11 (Tuesday) | 284 | USD 54,480 | USD 54,480 | 0 | USD 423 | USD 191.831 | USD 190.342 |
2025-02-10 (Monday) | 284 | USD 54,057 | USD 54,057 | 0 | USD -73 | USD 190.342 | USD 190.599 |
2025-02-07 (Friday) | 284 | USD 54,130 | USD 54,130 | 0 | USD -673 | USD 190.599 | USD 192.968 |
2025-02-06 (Thursday) | 284 | USD 54,803 | USD 54,803 | 0 | USD 346 | USD 192.968 | USD 191.75 |
2025-02-05 (Wednesday) | 284 | USD 54,457 | USD 54,457 | 0 | USD 511 | USD 191.75 | USD 189.951 |
2025-02-04 (Tuesday) | 284 | USD 53,946 | USD 53,946 | 0 | USD -54 | USD 189.951 | USD 190.141 |
2025-02-03 (Monday) | 284 | USD 54,000 | USD 54,000 | 0 | USD 1,772 | USD 190.141 | USD 183.901 |
2025-01-31 (Friday) | 284 | USD 52,228 | USD 52,228 | 0 | USD 2,343 | USD 183.901 | USD 175.651 |
2025-01-30 (Thursday) | 284 | USD 49,885 | USD 49,885 | 0 | USD 111 | USD 175.651 | USD 175.261 |
2025-01-29 (Wednesday) | 284 | USD 49,774 | USD 49,774 | 0 | USD 128 | USD 175.261 | USD 174.81 |
2025-01-28 (Tuesday) | 284 | USD 49,646 | USD 49,646 | 0 | USD -594 | USD 174.81 | USD 176.901 |
2025-01-27 (Monday) | 284 | USD 50,240 | USD 50,240 | 0 | USD 1,875 | USD 176.901 | USD 170.299 |
2025-01-24 (Friday) | 284 | USD 48,365 | USD 48,365 | 95 | USD 16,108 | USD 170.299 | USD 170.672 |
2025-01-23 (Thursday) | 189 | USD 32,257 | USD 32,257 | 0 | USD 278 | USD 170.672 | USD 169.201 |
2025-01-22 (Wednesday) | 189 | USD 31,979 | USD 31,979 | | | | |
2025-01-21 (Tuesday) | 189 | USD 32,623 | USD 32,623 | | | | |
2025-01-20 (Monday) | 183 | USD 31,395 | USD 31,395 | | | | |
2025-01-17 (Friday) | 183 | USD 31,395 | USD 31,395 | | | | |
2025-01-16 (Thursday) | 183 | USD 31,787 | USD 31,787 | | | | |
2025-01-15 (Wednesday) | 183 | USD 31,357 | USD 31,357 | | | | |
2025-01-14 (Tuesday) | 183 | USD 32,126 | USD 32,126 | | | | |
2025-01-13 (Monday) | 183 | USD 32,343 | USD 32,343 | | | | |
2025-01-10 (Friday) | 183 | USD 32,056 | USD 32,056 | | | | |
2025-01-09 (Thursday) | 183 | USD 32,666 | USD 32,666 | | | | |
2025-01-09 (Thursday) | 183 | USD 32,666 | USD 32,666 | | | | |
2025-01-09 (Thursday) | 183 | USD 32,666 | USD 32,666 | | | | |
2025-01-08 (Wednesday) | 183 | USD 32,666 | USD 32,666 | | | | |
2025-01-08 (Wednesday) | 183 | USD 32,666 | USD 32,666 | | | | |
2025-01-08 (Wednesday) | 183 | USD 32,666 | USD 32,666 | | | | |
2025-01-02 (Thursday) | 183 | USD 32,838 | USD 32,838 | 0 | USD 690 | USD 179.443 | USD 175.672 |
2024-12-30 (Monday) | 183 | USD 32,245 | USD 32,245 | | | | |
2024-12-10 (Tuesday) | 183 | USD 32,148 | USD 32,148 | 0 | USD -164 | USD 175.672 | USD 176.568 |
2024-12-09 (Monday) | 183 | USD 32,312 | USD 32,312 | 0 | USD 69 | USD 176.568 | USD 176.191 |
2024-12-06 (Friday) | 183 | USD 32,243 | USD 32,243 | 0 | USD 4 | USD 176.191 | USD 176.169 |
2024-12-05 (Thursday) | 183 | USD 32,239 | USD 32,239 | -188 | USD -33,228 | USD 176.169 | USD 176.461 |
2024-12-04 (Wednesday) | 371 | USD 65,467 | USD 65,467 | 0 | USD -1,870 | USD 176.461 | USD 181.501 |
2024-12-03 (Tuesday) | 371 | USD 67,337 | USD 67,337 | 0 | USD -100 | USD 181.501 | USD 181.771 |
2024-12-02 (Monday) | 371 | USD 67,437 | USD 67,437 | 0 | USD -430 | USD 181.771 | USD 182.93 |
2024-11-29 (Friday) | 371 | USD 67,867 | USD 67,867 | 0 | USD -56 | USD 182.93 | USD 183.081 |
2024-11-28 (Thursday) | 371 | USD 67,923 | USD 67,923 | 0 | USD 0 | USD 183.081 | USD 183.081 |
2024-11-27 (Wednesday) | 371 | USD 67,923 | USD 67,923 | 0 | USD 720 | USD 183.081 | USD 181.14 |
2024-11-26 (Tuesday) | 371 | USD 67,203 | USD 67,203 | 0 | USD 1,514 | USD 181.14 | USD 177.059 |
2024-11-25 (Monday) | 371 | USD 65,689 | USD 65,689 | -10 | USD -1,729 | USD 177.059 | USD 176.95 |
2024-11-22 (Friday) | 381 | USD 67,418 | USD 67,418 | 0 | USD 1,989 | USD 176.95 | USD 171.73 |
2024-11-21 (Thursday) | 381 | USD 65,429 | USD 65,429 | 0 | USD 1,512 | USD 171.73 | USD 167.761 |
2024-11-20 (Wednesday) | 381 | USD 63,917 | USD 63,917 | 0 | USD 454 | USD 167.761 | USD 166.57 |
2024-11-19 (Tuesday) | 381 | USD 63,463 | USD 63,463 | 0 | USD 110 | USD 166.57 | USD 166.281 |
2024-11-18 (Monday) | 381 | USD 63,353 | USD 63,353 | 0 | USD -1,832 | USD 166.281 | USD 171.089 |
2024-11-12 (Tuesday) | 381 | USD 65,185 | USD 65,185 | 95 | USD 8,128 | USD 171.089 | USD 199.5 |
2024-11-08 (Friday) | 286 | USD 57,057 | USD 57,057 | 96 | USD 18,960 | USD 199.5 | USD 200.511 |
2024-11-07 (Thursday) | 190 | USD 38,097 | USD 38,097 | 0 | USD -131 | USD 200.511 | USD 201.2 |
2024-11-06 (Wednesday) | 190 | USD 38,228 | USD 38,228 | 0 | USD -91 | USD 201.2 | USD 201.679 |
2024-11-05 (Tuesday) | 190 | USD 38,319 | USD 38,319 | 0 | USD 230 | USD 201.679 | USD 200.468 |
2024-11-04 (Monday) | 190 | USD 38,089 | USD 38,089 | 0 | USD -586 | USD 200.468 | USD 203.553 |
2024-11-01 (Friday) | 190 | USD 38,675 | USD 38,675 | 0 | USD -60 | USD 203.553 | USD 203.868 |
2024-10-31 (Thursday) | 190 | USD 38,735 | USD 38,735 | 0 | USD 450 | USD 203.868 | USD 201.5 |
2024-10-30 (Wednesday) | 190 | USD 38,285 | USD 38,285 | 0 | USD 2,289 | USD 201.5 | USD 189.453 |
2024-10-29 (Tuesday) | 190 | USD 35,996 | USD 35,996 | 0 | USD -43 | USD 189.453 | USD 189.679 |
2024-10-28 (Monday) | 190 | USD 36,039 | USD 36,039 | 0 | USD 347 | USD 189.679 | USD 187.853 |
2024-10-25 (Friday) | 190 | USD 35,692 | USD 35,692 | 0 | USD -342 | USD 187.853 | USD 189.653 |
2024-10-24 (Thursday) | 190 | USD 36,034 | USD 36,034 | 0 | USD 337 | USD 189.653 | USD 187.879 |
2024-10-23 (Wednesday) | 190 | USD 35,697 | USD 35,697 | 0 | USD -167 | USD 187.879 | USD 188.758 |
2024-10-22 (Tuesday) | 190 | USD 35,864 | USD 35,864 | 0 | USD 421 | USD 188.758 | USD 186.542 |
2024-10-21 (Monday) | 190 | USD 35,443 | USD 35,443 | 0 | USD -440 | USD 186.542 | USD 188.858 |
2024-10-18 (Friday) | 190 | USD 35,883 | USD 35,883 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of ABBV by Blackrock for IE000YNE6S57
Show aggregate share trades of ABBVDate | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
---|
2025-01-24 | BUY | 95 | | | 170.299* | | 184.41 |
2024-12-05 | SELL | -188 | | | 176.169* | | 186.19 Profit of 35,004 on sale |
2024-11-25 | SELL | -10 | | | 177.059* | | 188.21 Profit of 1,882 on sale |
2024-11-12 | BUY | 95 | | | 171.089* | | 195.47 |
2024-11-08 | BUY | 96 | | | 199.500* | | 195.19 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of ABBV
Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
---|
2025-03-11 | 941,353 | 3,972 | 2,234,612 | 42.1% |
2025-03-10 | 1,548,372 | 9,623 | 3,368,181 | 46.0% |
2025-03-07 | 811,393 | 1,757 | 2,627,653 | 30.9% |
2025-03-06 | 876,864 | 253 | 1,822,405 | 48.1% |
2025-03-05 | 867,206 | 3,994 | 2,328,308 | 37.2% |
2025-03-04 | 868,450 | 31,907 | 2,632,524 | 33.0% |
2025-03-03 | 1,235,403 | 38,403 | 2,981,453 | 41.4% |
2025-02-28 | 1,013,504 | 5,829 | 2,810,349 | 36.1% |
2025-02-27 | 854,220 | 4,285 | 2,382,573 | 35.9% |
2025-02-26 | 942,348 | 10,124 | 1,922,451 | 49.0% |
2025-02-25 | 1,156,824 | 281 | 3,249,891 | 35.6% |
2025-02-24 | 1,287,923 | 1,780 | 2,437,839 | 52.8% |
2025-02-21 | 981,309 | 741 | 1,915,617 | 51.2% |
2025-02-20 | 939,580 | 16,595 | 1,783,338 | 52.7% |
2025-02-19 | 842,784 | 2,570 | 1,660,890 | 50.7% |
2025-02-18 | 970,509 | 11,842 | 2,105,121 | 46.1% |
2025-02-14 | 880,176 | 3,830 | 1,569,917 | 56.1% |
2025-02-13 | 876,395 | 7,064 | 1,570,696 | 55.8% |
2025-02-12 | 1,031,507 | 8,654 | 2,003,759 | 51.5% |
2025-02-11 | 579,678 | 2,090 | 1,182,477 | 49.0% |
2025-02-10 | 666,183 | 3,605 | 1,389,547 | 47.9% |
2025-02-07 | 694,852 | 3,912 | 1,278,295 | 54.4% |
2025-02-06 | 1,088,999 | 6,280 | 1,677,637 | 64.9% |
2025-02-05 | 1,348,777 | 17,586 | 2,397,271 | 56.3% |
2025-02-04 | 1,409,964 | 8,216 | 2,897,438 | 48.7% |
2025-02-03 | 2,051,269 | 21,854 | 4,007,330 | 51.2% |
2025-01-31 | 2,412,562 | 21,356 | 4,094,927 | 58.9% |
2025-01-30 | 1,021,903 | 4,354 | 1,923,825 | 53.1% |
2025-01-29 | 665,948 | 10,918 | 1,421,744 | 46.8% |
2025-01-28 | 938,193 | 3,047 | 2,104,242 | 44.6% |
2025-01-27 | 684,097 | 20,333 | 2,567,248 | 26.6% |
2025-01-24 | 591,564 | 3,711 | 2,340,894 | 25.3% |
2025-01-23 | 703,068 | 1,554 | 2,035,584 | 34.5% |
2025-01-22 | 1,269,586 | 18,143 | 3,271,132 | 38.8% |
2025-01-21 | 1,142,499 | 532 | 2,393,015 | 47.7% |
2025-01-17 | 1,008,325 | 1,302 | 1,904,591 | 52.9% |
2025-01-16 | 750,668 | 4,270 | 1,825,789 | 41.1% |
2025-01-15 | 1,655,785 | 2,799 | 3,241,771 | 51.1% |
2025-01-14 | 1,219,719 | 1,725 | 1,957,003 | 62.3% |
2025-01-13 | 940,878 | 1,553 | 1,806,125 | 52.1% |
2025-01-10 | 1,234,715 | 1,060 | 1,975,164 | 62.5% |
2025-01-08 | 760,953 | 4,203 | 1,444,689 | 52.7% |
2025-01-07 | 689,037 | 5,863 | 1,470,206 | 46.9% |
2025-01-06 | 976,664 | 13,253 | 1,759,397 | 55.5% |
2025-01-03 | 792,300 | 1,027 | 1,457,793 | 54.3% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.